Newbridge Financial Services Group’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-308
Closed -$2K 1368
2022
Q2
$2K Hold
308
﹤0.01% 1149
2022
Q1
$2K Hold
308
﹤0.01% 1261
2021
Q4
$2K Hold
308
﹤0.01% 1210
2021
Q3
$3K Hold
308
﹤0.01% 1090
2021
Q2
$3K Hold
308
﹤0.01% 1193
2021
Q1
$4K Buy
+308
New +$3.66K ﹤0.01% 1054

Other funds holding ACHV

Newbridge Financial Services Group's ACHV Position: Q3 2022 in Review

Newbridge Financial Services Group sold out of Achieve Life Sciences (ACHV) in Q3 2022, closing a stake of 308 shares — an estimated $2K sold.

Newbridge Financial Services Group first reported a position in ACHV in Q1 2021 and held it in 6 quarters. The position peaked at $4K in Q1 2021. 28 funds tracked by Wall St. Rank hold ACHV as of Q3 2022.

  • Newbridge Financial Services Group reported no remaining Achieve Life Sciences position as of Q3 2022 after selling out during the quarter.
  • Newbridge Financial Services Group sold 308 Achieve Life Sciences shares in Q3 2022, an estimated $2K.
  • Newbridge Financial Services Group first reported a position in Achieve Life Sciences in Q1 2021 and held it in 6 quarters.
  • Newbridge Financial Services Group's Achieve Life Sciences position peaked at $4K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2022.

Based on Newbridge Financial Services Group's 13F filing for Q3 2022, filed 13 Oct 2022.